1Stockmeier F. Antidepressant discontinuation syndrome: an update on serotonin reuptake inhibitors[J]. J Clin Psychiatry,2003,58(Suppl 7) :543.
2Ossowska J, Peroutka M D. Dopamine and migraine [J]. Neurology, 1997,49(9): 650.
3Giogentti M,Bacciottini L. Local GABAergic modulation of acetylcholine release from cortex of freely movingrats[J]. Eur J Neurosci,2003,12(6): 1941 - 1948.
4Vetulani N E. Hypertrophy and increased gene expression of neurons containing neurokin-β and substance-P messenger ribonucteic acids in the hypothalami of postmonopausal woman [J]. Endocrinology,2003,128:2239 - 2247.
5Lascia A, Afa J, Schoenen J. Dopamine and migraine; a review of pharmacological, biochemical, neurophysiological,and therapeutic data[J]. Cephalalgia,2003,18(4):174.
6Klaiber V M. The epidemiology of estrogen replacement therapy in manepausal disease[J]. Neurology, 2003,48: 27 -35.
7Schneier K, Facchinetti F. Coping style and climacteric symptoms in a clinical sample of postmenopausal women[J].Journal of Psychosomatic Obstetrics and Gynaecology, 2003,18: 229 - 233.
8AIison A. Medicine nobel goes to raiders of the brain's chemical secrets[J]. Nature,2003,7:661.
9Grodstein F, Stampfer M J, Colditz G A, et al. Postmenopausal hormone therapy and mortality[J]. N Engl J Med, 2003,336:1769 - 1775.
10Wiklund. Methods of assessing the impact of climacteric complaints on quality of life[J]. Maturitas,2003,29:41-50.
